Abstract CT252: A dose escalation phase I study of concurrent GDC-0084 with radiation therapy for patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations.
Hi needle, the CT252 poster abstract was a conference paper for AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020.
Research Gate has no full text available. To read the full-text of this research, you can request a copy directly from the authors.
This is the Abstract CT252 links from Research Gate and AACR publications..
https://www.researchgate.net/publication/345210544_Abstract_CT252_A_dose_escalation_phase_I_study_of_concurrent_GDC-0084_with_radiation_therapy_for_patients_with_solid_tumor_brain_metastases_or_leptomeningeal_metastases_harboring_PI3K_pathway_mutation
https://cancerres.aacrjournals.org/content/80/16_Supplement/CT252
Regards.
- Forums
- ASX - By Stock
- Ann: Kazia's paxalisib SNO data
Abstract CT252: A dose escalation phase I study of concurrent...
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online